Loading organizations...
Loading organizations...
Developer of regenerative therapies for neurodegenerative disorders.
Innervace has raised $40.0M across 1 funding round.
Innervace has raised $40.0M in total across 1 funding round.
Innervace has raised $40.0M in total across 1 funding round.
Innervace's investors include David Greenwald, BioAdvance, Penn Medicine, WARF Ventures.
Innervace has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 8, 2022 | $40.0M Series A | David Greenwald | BioAdvance, Penn Medicine, WARF Ventures |